
ABBOTT LABORATORIES — Investor Relations & Filings
Abbott Laboratories is a global healthcare company that discovers, develops, manufactures, and sells a broad portfolio of life-changing technologies. The company's operations are focused on four core businesses: Medical Devices, Diagnostics, Nutrition, and Established Pharmaceuticals. The Medical Devices division offers solutions for cardiovascular health, diabetes care (including the FreeStyle Libre continuous glucose monitoring system), and neuromodulation. The Diagnostics segment provides a wide range of in vitro diagnostic systems and tests for hospitals, laboratories, and clinics. The Nutrition business develops and markets science-based nutritional products for people of all ages, with leading brands such as Similac, PediaSure, Ensure, and Glucerna. The Established Pharmaceuticals division provides a portfolio of branded generic medicines to consumers in emerging markets.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| S-8 - ABBOTT LABORATORIES (0000001800) (Filer) | 2026-04-24 | English | |
| 8-K - ABBOTT LABORATORIES (0000001800) (Filer) | 2026-04-17 | English | |
| 8-K - ABBOTT LABORATORIES (0000001800) (Filer) | 2026-04-16 | English | |
| SCHEDULE 13G/A - ABBOTT LABORATORIES (0000001800) (Subject) | 2026-03-26 | English | |
| 4 - ABBOTT LABORATORIES (0000001800) (Issuer) | 2026-03-25 | English | |
| 3 - ABBOTT LABORATORIES (0000001800) (Issuer) | 2026-03-25 | English |
| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
15 filings
| |||||
| 36260641 | S-8 - ABBOTT LABORATORIES (0000001800) (Filer) | 2026-04-24 | English | ||
| 34661940 | 8-K - ABBOTT LABORATORIES (0000001800) (Filer) | 2026-04-17 | English | ||
| 34647007 | 8-K - ABBOTT LABORATORIES (0000001800) (Filer) | 2026-04-16 | English | ||
| 33051650 | SCHEDULE 13G/A - ABBOTT LABORATORIES (0000001800) (Subject) | 2026-03-26 | English | ||
| 33043414 | 4 - ABBOTT LABORATORIES (0000001800) (Issuer) | 2026-03-25 | English | ||
| 33043382 | 3 - ABBOTT LABORATORIES (0000001800) (Issuer) | 2026-03-25 | English | ||
| 33016698 | S-8 - ABBOTT LABORATORIES (0000001800) (Filer) | 2026-03-23 | English | ||
| 33013457 | 8-K - ABBOTT LABORATORIES (0000001800) (Filer) | 2026-03-23 | English | ||
| 32874359 | 4 Filing | 2026-03-04 | English | ||
| 32874360 | 4 Filing | 2026-03-04 | English | ||
| 32874361 | 4 Filing | 2026-03-04 | English | ||
| 32874362 | 4 Filing | 2026-03-04 | English | ||
| 32874363 | 4 Filing | 2026-03-04 | English | ||
| 32874364 | 4 Filing | 2026-03-04 | English | ||
| 32874365 | 4 Filing | 2026-03-04 | English | ||
Market data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
Acrivon Therapeutics, Inc.
Clinical-stage biopharma using proteomics to develop precis…
|
ACRV | US | Manufacturing |
|
ACRUX LIMITED
Develops and commercializes topical and transdermal drug de…
|
ACR | AU | Manufacturing |
|
Acticor Biotech
Develops treatments for thrombotic diseases, focusing on ac…
|
ALACT | FR | Manufacturing |
|
Actinium Pharmaceuticals, Inc.
Clinical-stage company developing targeted radiotherapies f…
|
ATNM | US | Manufacturing |
|
ACTUATE THERAPEUTICS, INC.
Clinical-stage biopharma developing therapies for cancers w…
|
ACTU | US | Manufacturing |
|
AcuCort AB
Develops user-friendly drug formulations for severe and acu…
|
ACUC | SE | Manufacturing |
|
Acumen Pharmaceuticals, Inc.
Clinical-stage biopharma developing targeted therapies for …
|
ABOS | US | Manufacturing |
|
Acurx Pharmaceuticals, Inc.
Clinical-stage biopharma developing a new class of antibiot…
|
ACXP | US | Manufacturing |
|
Adaptimmune Therapeutics PLC
Commercial-stage biopharma developing TCR T-cell therapies …
|
ADAP | GB | Manufacturing |
|
Adaptogenics Health Corp.
Formulates and distributes functional mushroom and adaptoge…
|
ADPT | CA | Manufacturing |
ABBOTT LABORATORIES via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/29777/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=29777 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=29777 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=29777 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 29777}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for ABBOTT LABORATORIES (id: 29777)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.